U.S. Hospitality Stock News

The FDA's Center for Drug Evaluation and Research has proposed that Amgen withdraw its drug Tavneos, citing untrue statements of material facts and possible data manipulation in clinical trial data. Regulators also questioned whether existing evidence is sufficient to support Tavneos's effectiveness. The proposal raises concerns about Amgen's regulatory controls, data transparency, and risk oversight as the company grows in biopharmaceuticals. For investors watching Amgen, ticker...

Eaton (ETN) is drawing attention after a recent move in its share price, with the stock showing mixed short term returns despite a positive month and past 3 months performance profile. See our latest analysis for Eaton. The recent pullback, with a 1-day share price return of 0.56% and 7-day share price return of 0.75%, sits against a 30-day share price return of 19.57% and a 1-year total shareholder return of 41.25%. If Eaton's move has you watching the power and infrastructure space more...

New Navy task order puts fresh attention on SAIC Science Applications International (SAIC) just secured a new US$75.2 million task order to support Naval Air Systems Command, highlighting the company’s role in digital engineering, predictive analytics, and long running Navy programs. See our latest analysis for Science Applications International. The new Navy task order comes at a time when the share price is around US$95.13, with a 90 day share price return of a 6.52% decline and a 1 year...

Wondering if GXO Logistics at around US$55 a share still offers value, or if most of the opportunity is already priced in. The stock has had a mixed short term patch, with a 3.9% decline over the last 7 days, a 12.9% gain over the last 30 days, a 1.6% return year to date, and a 52.2% return over the past year. Recent coverage has focused on GXO Logistics as a pure play contract logistics provider and how its role in global supply chains frames investor expectations. Ongoing commentary around...

ICF International (ICFI) has drawn investor attention after recent share price swings, including a decline of about 26% over the past 3 months, prompting a closer look at its current valuation and fundamentals. See our latest analysis for ICF International. While the share price has recently been under pressure, with a 90 day share price return of about negative 26.5% and a 1 year total shareholder return of about negative 19%, the past month’s share price recovery suggests some short term...

Envista Holdings overview and recent share performance Envista Holdings (NVST) has drawn investor attention after recent share price moves, with the stock showing a mix of short term weakness over the past week and a gain over the past month. Over the past day Envista recorded a 2.2% decline, with a 4.6% decline across the past week. That contrasts with a positive return over the past month and past 3 months, alongside a higher total return over the past year. See our latest analysis for...

In recent days, Marvell Technology canceled all Celestial AI-related purchase orders after accusing POET Technologies of breaching confidentiality by publicly disclosing sensitive order details. This dispute highlights how Marvell’s push deeper into custom AI and photonics partnerships also increases its exposure to complex supplier and confidentiality risks. We’ll now examine how canceling Celestial AI-linked orders after POET’s confidentiality breach affects Marvell’s AI-focused...

In late April 2026, Cisco Systems announced its Universal Quantum Switch, a room-temperature device designed to route and convert quantum information across multiple encoding types over standard telecom fiber while preserving coherence, alongside strong Q2 FY2026 results driven by AI-focused infrastructure demand and raised full-year guidance. This combination of cutting-edge quantum networking research and AI-oriented networking momentum underlines Cisco’s ambition to build a full-stack...

Why IPG Photonics (IPGP) is back on investors’ radar IPG Photonics (IPGP) has drawn fresh attention after recent trading, with the stock closing at $113.26 and short term returns sending mixed signals across the past week, month, and past 3 months. See our latest analysis for IPG Photonics. The recent 1 day share price return of 0.80% comes after a weaker 7 day patch and a modest 30 day decline. However, the 90 day share price return of 22.56% and year to date share price return of 51.34% sit...

If you are wondering whether IDEXX Laboratories at around US$553.66 is still a quality opportunity or already pricing in a lot of optimism, the next sections walk through what the current valuation is actually telling you. Over the last week and month, the share price is modestly lower, with returns of a 1.3% decline and a 1.5% decline, while the longer-term picture shows 17.5% over 1 year and 17.9% over 3 years, with 3.8% over 5 years and a 17.4% decline year to date. Recent coverage has...

If you are wondering whether Radian Group at around US$37.31 still offers value, the key question is how its current price compares with what the business may reasonably be worth. The stock has recently shown solid returns, with 4.9% over the last 7 days, 12.8% over 30 days, 3.9% year to date, 20.3% over 1 year, 73.2% over 3 years, and 86.2% over 5 years. Recent coverage has focused on Radian Group's position in the diversified financials space and how the market is reassessing risk and...

For investors wondering whether CarGurus at around US$36.67 is still offering value or if the easy gains are behind it, this piece focuses on what the current price implies. The stock has returned 31.4% over the last year, with a 7.7% move over the past month and a 2.2% pullback in the last week that may have shifted the near term risk reward balance. Recent coverage has focused on CarGurus as an established online auto marketplace and its role in connecting dealers and car buyers. This...

Dyne Therapeutics, Inc. recently announced preclinical data showing its FORCE platform can cross the blood-brain barrier and achieve robust MAPT RNA knockdown in the central nervous system in mice and nonhuman primates, using two TfR1-targeting siRNA conjugates that also worked via subcutaneous dosing. This work suggests Dyne’s clinically validated FORCE platform, originally built for neuromuscular diseases, may be extendable to neurological conditions linked to tau pathology such as...

Investors may be wondering whether ITT’s current share price reflects its true worth, or if the recent gains have pushed it too far. ITT shares last closed at US$212.30, with returns of 17.3% over 30 days, 21.9% year to date, and 56.2% over 1 year, while the 7 day return came in at a 2.2% decline. Recent market attention around ITT has focused on its share price performance over multiple time frames. This has put valuation firmly in the spotlight for many investors. That shift in focus makes...

Greif stock performance snapshot after recent trading moves Greif (GEF) shares recently closed at US$65.44, with the stock showing a 1 day return of 1.28% and a 7 day decline of 1.86%. This sets the stage for a closer performance review. See our latest analysis for Greif. While the recent 7 day share price return of a 1.86% decline and 90 day share price return of a 6.65% decline point to fading near term momentum, the 1 year total shareholder return of 29.01% and 5 year total shareholder...

Omega Healthcare Investors, Inc. reported strong first-quarter 2026 results, with revenue rising to US$322.96 million and net income to US$151.05 million, while also recording lower real estate impairments and maintaining a US$0.67 per-share dividend declared earlier in April. The quarter was also marked by US$251 million of new investments, including facility acquisitions and a 9.9% equity stake in Saber Healthcare Holdings, alongside an expected US$480 million asset sale that underscores...

As an investor trying to work out whether Ormat Technologies is attractively priced, it helps to start by asking what the recent share performance is really telling you about expectations already baked into the stock. At a last close of US$110.32, the share price reflects returns of 3.1% over the past week, 0.8% over the past month, a 3.0% decline year to date, and 52.7% over the past year. Over three and five years, the returns are 34.1% and 65.9% respectively. This gives you a wide range of...

Teladoc Health, Inc. recently reported first-quarter 2026 results, with sales of US$613.85 million compared to US$629.37 million a year earlier and a net loss of US$63.84 million versus US$93.01 million previously, alongside basic and diluted loss per share from continuing operations of US$0.36 compared with US$0.53. The combination of slightly lower revenue but a narrower loss suggests Teladoc is making some progress on cost control and efficiency even as top-line momentum softens. With...

If you are wondering whether NVR at around US$6,207.50 a share is priced fairly or not, the key is understanding what different valuation methods are saying about the stock right now. The share price return sits at a 6.1% decline over the last 7 days, a 4.5% decline over 30 days, and a 14.7% decline year to date. Over 1 year the return is a 12.9% decline, compared with gains of 5.3% over 3 years and 20.7% over 5 years. These mixed returns can sometimes follow shifts in investor sentiment...

American Water Works Company, Inc. has reported past first-quarter 2026 results, with sales rising to US$1,207 million while net income eased to US$196 million, leading to lower earnings per share than a year earlier. Alongside these mixed financials, the company and its charitable foundation have continued funding water and environmental initiatives across several states, highlighting an ongoing emphasis on infrastructure, quality, and community impact. We’ll now examine how the quarterly...

Mondelez International (MDLZ) opened 2026 with Q1 revenue of US$10.1b and basic EPS of US$0.44, alongside net income of US$560m, setting the tone for a results season where profitability sits firmly in focus. The company has seen quarterly revenue move from US$9.3b in Q1 2025 to US$10.1b in Q1 2026, while basic EPS shifted from US$0.31 to US$0.44 over the same period. This gives you a clear view of how the top and bottom lines have tracked year on year. With trailing twelve month EPS at...

Scorpio Tankers Inc. recently received a commitment from Bank of America for a US$50 million credit facility to finance two 2015-built LR2 product tankers, while also agreeing to sell six 2014-built vessels for a combined US$300 million as part of its fleet reshaping efforts. These past-week moves highlight how Scorpio Tankers is actively recycling capital, selling older vessels, adding financing for mid-life ships, and repositioning its fleet across LR2, MR, Handymax, and future VLCC...

Penny stocks often fall over when cash runs thin, which is why balance sheet strength matters even more when inflation, energy costs and interest rate expectations keep markets on edge. The Elite Penny Stocks screener focuses on smaller names that still have the financial resources to pursue their growth plans, instead of relying on hope and dilution. If you are looking for potential multi-baggers but want a more disciplined way to sort the field, this is a focused starting point. Below, you...

Investors may be wondering whether Devon Energy's share price still offers value after a strong run, or if most of the opportunity is already priced in. The stock recently closed at US$51.08, with returns of 8.4% over 7 days, a 0.9% decline over 30 days, 34.9% year to date and 72.3% over the past year. Recent headlines around Devon Energy have focused on its role within the broader energy sector and how investors are reassessing risk and opportunity in oil and gas names. That backdrop helps...